全文获取类型
收费全文 | 1272篇 |
免费 | 68篇 |
国内免费 | 34篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 43篇 |
妇产科学 | 18篇 |
基础医学 | 115篇 |
口腔科学 | 9篇 |
临床医学 | 64篇 |
内科学 | 183篇 |
皮肤病学 | 17篇 |
神经病学 | 34篇 |
特种医学 | 13篇 |
外科学 | 126篇 |
综合类 | 188篇 |
预防医学 | 59篇 |
眼科学 | 4篇 |
药学 | 257篇 |
中国医学 | 64篇 |
肿瘤学 | 177篇 |
出版年
2023年 | 4篇 |
2022年 | 25篇 |
2021年 | 29篇 |
2020年 | 25篇 |
2019年 | 19篇 |
2018年 | 31篇 |
2017年 | 41篇 |
2016年 | 31篇 |
2015年 | 28篇 |
2014年 | 78篇 |
2013年 | 79篇 |
2012年 | 58篇 |
2011年 | 82篇 |
2010年 | 40篇 |
2009年 | 48篇 |
2008年 | 83篇 |
2007年 | 63篇 |
2006年 | 53篇 |
2005年 | 48篇 |
2004年 | 43篇 |
2003年 | 37篇 |
2002年 | 30篇 |
2001年 | 45篇 |
2000年 | 36篇 |
1999年 | 36篇 |
1998年 | 21篇 |
1997年 | 22篇 |
1996年 | 18篇 |
1995年 | 20篇 |
1994年 | 21篇 |
1993年 | 8篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 15篇 |
1989年 | 7篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 7篇 |
1985年 | 17篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1980年 | 10篇 |
1979年 | 19篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 3篇 |
1972年 | 2篇 |
1970年 | 1篇 |
排序方式: 共有1374条查询结果,搜索用时 15 毫秒
1.
猕猴桃汁抗环磷酰胺致突变作用的机理 总被引:12,自引:1,他引:11
目的用大鼠外周血双核淋巴细胞微核测试法(CBMNT),在哺乳动物整体水平,研究猕猴桃汁抗环磷酰胺(CP)的致突变作用以及生物转化Ⅱ相酶的作用。方法测定大鼠外周血双核淋巴细胞微核细胞率及肝组织中总谷胱甘肽硫转移酶(GST)、尿苷二磷酸葡萄糖醛酸转移酶(UDPGT)、谷氨酰胺转肽酶(γGT)活性。结果猕猴桃汁对CP诱发的大鼠外周血双核淋巴细胞微核细胞率有显著抑制作用,能明显诱导大鼠肝脏总GST、UDGTP活性,但对γGT活性无显著影响。大鼠外周血双核淋巴细胞微核细胞率与总GST、UDGTP活性呈明显负相关。结论猕猴桃汁抗CP致微核形成作用的机理可能是通过诱导机体外来化合物代谢解毒酶系,加速CP的代谢灭活 相似文献
2.
用有机锗(Ge-132)试验治疗荷移植肝癌小鼠。结果:De-132高剂量(12.5mg/次)治疗组的抑癌率为用31.0%,移植肝癌白细胞(WBC)浸润(+++)占72.7%、血清超氧化物歧化酶(SOD)活性为121Nu/ml,而生理盐水对照治疗组相应的后两项指标分别为用36.4%及81Nu/ml,两组比较有显著性差异(P<0.05);环磷酰胺(CTX)治疗组的抑癌率为37.0%,癌体WBC浸润(+++)为27.3%,血清SOD活性为102Nu/ml;ge-132高剂量与CTX2联合治疗组的抑癌率为45.0%,癌体WBC浸润(+++)为54.5%,血清SOD活性为142Nu/ml,两组比较,后二项指标有显著性差异(P<0.05)。由此提示Ge-132高剂量能明显增强荷移植肝癌小鼠的细胞免疫及血清SOD活性,并有一定的抗移植肝癌作用。 相似文献
3.
鼠脑缺血再灌注损伤炎症反应及环磷酰胺影响 总被引:8,自引:0,他引:8
目的 探讨脑缺血再灌注不同缺血区域炎症反应特点及环磷酰胺影响.方法 将大鼠随机分为假手术组、对照组、环磷酰胺预处理组,建立局灶性脑缺血再灌注模型.用免疫组化法和生化法观察额顶部皮质和基底节区P-选择素表达、髓过氧化物酶(MPO)活性变化;并进行TTC染色和HE染色.结果 (1)再灌注3h缺血侧额顶部皮质和基底节区出现P-选择素表达,12h达高峰.环磷酰胺预处理组和对照组相比较,差异无显著性(P>o.05).(2)再灌注12h以后MPO活性明显升高.基底节区的MPO活性在再灌注48h达到高峰后下降.额顶部皮质MPO活性在再灌注24h达到高峰后至96h仍维持较高水平.和对照组相比较,环磷酰胺预处理组MP(活性升高受抑制(P<0.05).(3)环磷酰胺预处理可显著缩小脑梗死体积(P<0.05).结论 (1)脑缺血再灌注损伤存在主动性炎症反应,额顶部皮质比基底节区的炎症反应更持久和剧烈.(2)环磷酰胺减少缺血侧中性粒细胞浸润数量,具有神经保护作用,但不直接影响P-选择素的表达. 相似文献
4.
The effect of Panaxatriol Ginsenoside (PTGS) on Immune functions in bone marrow suppressed mice induced by injection of cyclophosphamide (CY) has been studied. Bone marrow suppressed mice were made by injection of CY (150 mg/kg) parenterally. Subcutaneous injection of PTGS three days earlier partially restored the number and the activity of bone marrow cells, significantly enhanced the production of IL-1, IL- 3 and IL- 6 like substances and promoted the reactivity of murlne spleen cells to Con-A In bone marrow suppressed mice. 相似文献
5.
HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome 总被引:2,自引:0,他引:2
Martin Konrad Joannis Mytilineos Hans Ruder Gerhard Opelz Karl Schärer 《Pediatric nephrology (Berlin, Germany)》1997,11(1):16-19
There is a lack of reliable predictors of the response to alkylating agents in children with idiopathic nephrotic syndrome
(NS). HLA-DR7 is strongly associated with the frequency of relapses in steroid-sensitive NS before cytostatic therapy. We
therefore examined retrospectively the time to the first relapse and the incidence of subsequent relapses in 54 HLA-typed
children with frequently relapsing NS, after treatment with cyclophosphamide (n = 49) or chlorambucil (n = 5) for 8 or 12 weeks; 38 patients were HLA-DR7 positive and 16 negative with 80% in both groups being steroid dependent.
HLA typing was performed using serological or DNA typing methods. Renal biopsy showed minimal glomerular changes. A lower
proportion of HLA-DR7 positive than negative patients remained in remission after 3 years (36% vs. 81%, P<0.02) and 5 years (36% vs. 72%, P<0.03). In the first 3 years after cytostatic therapy the mean number of prednisone-treated relapses was 1.3/patient per year
in HLA-DR7-positive patients compared with 0.4 in negative patients (P<0.025). There was no statistically significant difference in the proportion of relapse-free patients with and without steroid
dependency. The HLA status predicts the response of NS patients to alkylating agents better than the rate of previous relapses.
Received September 19, 1995; received in revised form and accepted April 16, 1996 相似文献
6.
本文报道以黄芪、女贞子、墨旱莲三合剂(AFE)大小剂量(9g/kg、20g/kg)分别给予小鼠灌胃7天,观察其对机体细胞免疫及体液免疫功能的影响。结果表明,两种剂量的AFE均能非常明显地增加小鼠细胞免疫功能(P<0.01),促进其免疫器官正常发育(P<0.05),提高血清IgG水平(>40%)。增加小鼠免疫生化酶一腺苷脱氨酶(ADA)活性,其中大剂量组对ADA的影响具有非常显著性意义(P<0.01)。该合剂还具有恢复环磷酰胺对小鼠免疫器官所致的萎缩作用。提示.该中药合剂可保护、提高小鼠免疫功能。 相似文献
7.
蟾酥注射液对小鼠S180和人结肠癌HT-29裸鼠移植性肿瘤的影响 总被引:6,自引:0,他引:6
目的研究蟾酥注射液对小鼠移植性肿瘤 S180和人结肠癌 HT-29裸鼠移植性肿瘤的抑制作用.方法分别用小鼠 S180和人结肠癌 HT-29裸鼠两种荷瘤小鼠模型,观察药物对上述肿瘤的抑瘤作用,并镜下观察后者细胞凋亡情况.结果与荷瘤阴性对照组比较,蟾酥注射液各剂量组对小鼠 S180抑瘤率( IR)为 19.1%~38.2%(P<0.05),呈量效关系;而对人结肠癌 HT-29裸鼠移植性肿瘤的 IR为 9.5%~15.8%(P>0.05),也呈量效关系,但差异均未见统计学意义;环磷酰胺则能显著抑制小鼠 S180和 HT-29细胞裸鼠移植性肿瘤的生长( IR分别为70.7%和 67.1%, P<0.01),镜检可见其有显著促进肿瘤细胞凋亡作用;未发现实验药物出现明显的毒副作用.结论该实验所用的蟾酥注射液,对小鼠 S180有抑制作用,而对人结肠癌 HT-29裸鼠移植性肿瘤,则作用不明显,表明不同类型的肿瘤对其敏感性不同. 相似文献
8.
Otoniel Martínez-Maza Dewey J. Moody Ali R. Rezal George W. Ellison Lawrence W. Myers Wallace W. Tourtellotte John L. Fahey 《Journal of clinical immunology》1987,7(2):107-113
Spontaneous immunoglobulin (Ig) secretion by cells from multiple sclerosis (MS) patients (in the progressive phase) treated with monthly pulse doses of cyclophosphamide (CY) (1000–1600 mg/M2) was measured using the protein A plaque assay, to evaluate the effect of CY treatment on B-cell function. Surprisingly, an increase, rather than a decrease, in Ig-secreting cells was seen following CY treatment. CY-treated MS patients averaged 1380±535 spontaneous total (IgM+G+A) Ig plaque-forming cells (PFC) per 1×106 peripheral blood mononuclear cells (MNC), measured at 15–22 days after monthly CY administration, while healthy adults had 280±47 Ig PFC/106 MNC, and MS patients not treated with CY had 300±43 Ig PFC/106 MNC. The observed increase was due to an increase in IgG and IgA PFC. PFC levels remained elevated for 4 weeks following CY treatment, decreasing to control levels by 7–8 weeks post-CY. A small increase in serum IgG level was noted after >12 months of pulse CY therapy; no increase was seen in CSF IgG levels. A preferential decrease in the number of CD4+ T cells was also seen in the CY-treated MS patients. We propose that the observed increase in the number of spontaneous Ig PFC was due to the CY-induced disruption of the CD4+ T cell-mediated control ofin vivo activated B cells. 相似文献
9.
R. C. P. Lima-Júnior D. I. M. Sousa G. A. C. Brito G. M. Cunha M. H. Chaves V. S. N. Rao F. A. Santos 《Inflammation research》2007,56(12):487-494
Objective and design: We previously described the visceral antinociceptive property of α, β-amyrin in a mouse model of cystitis induced by cyclophosphamide
(CPM). This study examined the contribution of vanilloid-1 (TRPV1), peripheral NK1 receptors to CPM-evoked nociceptive behaviors
and bladder edema, and its possible modulation by α, β-amyrin.
Methods: The effect of α, β-amyrin (10, 30, and 100 mg/kg, p. o.) and N-acetylcysteine (NAC) on CPM (400 mg/kg, i. p.)-induced cystitis
was studied in mice. Sensory deafferentation was done by a high dose capsaicin. The parameters analysed were: CPM-evoked noxious
behaviors, bladder edema, vascular permeability, and NK1 immunoreactivity. To assess the role of K+
ATP channels in α, β-amyrin effect, animals were pretreated with glibenclamide.
Results: α, β-amyrin (30 and 100 mg/kg) and NAC significantly (p < 0.01) suppressed the visceral pain-related behaviors and NK1 immunoreactivity, but bladder edema was reduced weakly. Glibenclamide reversed the effects of α, β-amyrin. Sensory deafferentation
by capsaicin significantly reduced the nociceptive responses and the NK1 immunoreactivity to noxious stimulation by CPM.
Conclusions: α, β-amyrin attenuates CPM-induced visceral pain and bladder edema by mechanisms that involve, at least in part, a block either
of Substance P release or its receptor function, and partly by opening K+
ATP channels.
Received 13 February 2007; returned for revision 13 April 2007; accepted by G. Geisslinger 14 May 2007 相似文献
10.
The effects of thermochemotherapy using cyclophosphamide plus hyperthermia on the malignant pleural mesothelioma in vivo 总被引:2,自引:0,他引:2
The human malignant pleural mesothelioma is related to the use of asbestos in the majority of cases. Though the use of asbestos has been prohibited since the 1990s, the incidence of pleural mesothelioma is still increasing because of a latency period of at least 20 years. This study investigated the benefit of single therapy with cyclophosphamide or hyperthermia or the combination of both on cells of a human pleural mesothelioma cell line, xenotransplanted subcutaneously in the paw of mice. A CONTROL group received the same volume of physiological saline. The oxygenation of tumours was measured, tumour growth was followed over 3 weeks, immunohistochemical studies and a light and electron microscopic evaluation were performed. Chemotherapy or hyperthermia alone was only temporarily effective. The greatest benefit was achieved using combined thermochemotherapy consisting of cyclophosphamide plus hyperthermia: 50% of this group had partial remissions, and 67% responded to this therapy. After 3 weeks tumours grew again. Superior effects could be achieved by performing additional cycles of chemotherapy or adding another drug or radiation for instance. This study shows promising results in the treatment of malignant pleural mesothelioma. 相似文献